Financials
- Fiscal year
- 2024
- Total assets
- €340,634
- Loss
- -€47,903
- Solvency
- 19.2%
Turnover▼ 2.3%
Net result
20192023
NATHYPHARM
ActiveSummary
The computed 12-month bankruptcy probability of NATHYPHARM is 3.1% (moderate). The 2024 annual accounts show equity of €65,374 and a net result of -€47,903. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 38% of 26034 sector peers (fiscal year 2024). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€340,634total assets 2024
- Equity
- €65,374
- Loss
- -€47,903
Turnover not published (abridged schema)
Structure
Accounts filed 62 d late0 of 1 deed read
Why 49- 1 financial year not filed after the legal deadline; latest accounts 62 days late; 1 of the last 3 late- Figures for FY 2024 (filed 07-10-2025)+ Founded in 2011+ Size: total assets €340,634Show the evidence
Checked score
Score 2024
49
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 29% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Weak
Solvency
44-11
equity 19.2% of total assets
Liquidity
42+28
short-term debt 26.8% · cash 2.1%
Profitability
1-79
return on assets -14.1%
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 16 months
07-2025: 4.3%
08-2025: 4.3%● 0.0% vs 07-2025
09-2025: 4.3%▲ +0.7% vs 08-2025highest value
10-2025: 3.9%▼ -8.9% vs 09-2025
11-2025: 2.2%▼ -44.1% vs 10-2025
12-2025: 2.2%● 0.0% vs 11-2025
01-2026: 2.2%▼ -1.5% vs 12-2025
02-2026: 2.2%● 0.0% vs 01-2026
03-2026: 2.2%▼ -0.6% vs 02-2026
04-2026: 2.2%▲ +1.5% vs 03-2026
05-2026: 2.2%● -0.0% vs 04-2026
06-2026: 2.1%▼ -2.9% vs 05-2026lowest value
07-2026: 2.1%▲ +1.1% vs 06-2026
08-2026: 2.8%▲ +30.0% vs 07-2026
09-2026: 2.9%▲ +2.7% vs 08-2026
10-2026: 3.1%▲ +8.3% vs 09-2026
- 1 financial year not filed after the legal deadline; latest accounts 62 days late; 1 of the last 3 late raises the probability
- Figures for FY 2024 (filed 07-10-2025) raises the probability
- Founded in 2011 lowers the probability for this profile
- Size: total assets €340,634 lowers the probability for this profile
Credit up to €3,000 at 30 days acceptable
Liquidity short (current ratio 0.14 against 0.11 in 2023; short-term debt: 26.8% and cash: 2.1% of total assets), and 80.8% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 35%, liquidity 40%, profitability 13%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-10-2025, 62 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2024
62 d late
2023
22 d early
2022
on the day
2021
18 d early
2020
20 d early
2019
24 d early
2018
16 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 5 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
- Weakest financial yearnet -€47,903
- Annual accounts filedfiscal year 2023 · micro…
Key points
By topic
Timeline
- Events
- 14
- Since
- 2015
- 01-10-2025Annual accounts filed
- 31-12-2024Weakest financial year
- 09-01-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 04-07-2011
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.